Morgan Stanley (NYSE:MS) initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming ...

“We have argued that the risk from Japan’s Upper House election to be held on July 20 is skewed to a weaker yen with a rise in volatility in the case of a loss by the ruling coalition party,” said ...

Morgan Stanley (NYSE: MS) has begun coverage of Genmab (CSE: GMAB) (NASDAQ: GMAB) with an Equal-Weight rating and a price ...